Abstract The purpose of this study is to evaluate surface papillary epithelial hyperplasia, a microscopic finding that corresponds to the clinical finding of rough or stippled mucosa, as a predictor of polymorphous low-grade adenocarcinoma (PLGA). We conducted a retrospective review of minor salivary gland neoplasms submitted to our biopsy service from 1991 to 2013. Our review was limited to lesions involving the oral cavity/soft palate with the following diagnoses: PLGA, pleomorphic adenoma (PA), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC). A total of 202 minor salivary gland neoplasms were included in the study. Among cases in which surface epithelium was present for evaluation (n = 112), surface papillary epithelial hyperplasia was evident in 30 % of PLGA and 1 % of non-PLGA (i.e., MEC, ACC, PA). The greater frequency of surface papillary epithelial hyperplasia in the PLGA versus non-PLGA cases and in the benign versus malignant cases was significant (p = .0001 and p = .041, respectively). The sensitivity and specificity of papillary epithelial hyperplasia for PLGA were 30 % (95 % confidence interval (CI) 11.97-54.27 %) and 99 % (95 % CI 94-99.82 %), respectively. The clinical presentation of PLGA appeared relatively nonspecific, with all analyzed tumor types exhibiting a predilection for females, middle-aged to older adults, palatal location, pink/tan/normal color, and firm consistency. In conclusion, papillary epithelial hyperplasia was evident in only a minority of PLGA. However, when present within the context of a palatal salivary gland neoplasm, it appears to indicate a high probability of PLGA. Accordingly, rough mucosa may be a useful clinical pearl for identification of PLGA.
Introduction
Polymorphous low-grade adenocarcinoma (PLGA) is lowgrade malignant neoplasm that primarily originates from minor salivary glands. Its true frequency is difficult to determine because of differences across studies in tumor classification, diagnostic criteria, and patient populations. In previously published large-scale series, the relative frequency of PLGA varies from 0 to 16 % among intraoral minor salivary gland neoplasms and 0 to 47 % among intraoral minor salivary gland malignancies. Despite this considerable variation, numerous studies have reported that PLGA represents either the second or third most common malignant minor salivary gland tumor [1] [2] [3] [4] .
According to descriptions in the current literature, the clinical presentation of PLGA is nonspecific. The tumor has been reported among patients over a broad age range (2nd through 10th decades of life). Similar to other salivary gland neoplasms, PLGA exhibits a predilection for females and middle-aged to older individuals. The tumor typically consists of a firm, nontender swelling of the palate, buccal mucosa, or upper lip, with an appearance likened to a host of other salivary gland tumors and soft tissue tumors. Pain and discomfort are variable findings. The surface epithelium often appears normal, although telangiectasias, ulceration, and bleeding may be evident in some cases [5] . However, such surface changes can be found in association with numerous other tumor types as well.
Interestingly, we have noted several cases of PLGA in which the surface epithelium clinically exhibits a rough or stippled appearance (Fig. 1a, b, d ). This finding may be appreciated most readily after drying the mucosa (Fig. 1c,  d ). In each of these cases, microscopic examination of this rough mucosa shows mild papillary hyperplasia of the surface epithelium overlying the tumor (Fig. 1e, f) . To the best of our knowledge, such change in the surface epithelium overlying PLGA or other salivary neoplasms has not been described previously.
Our overall objective is to address whether various clinicopathologic parameters may be useful in narrowing the clinical differential diagnosis for patients with minor salivary gland neoplasms. The main purpose of this study is to evaluate surface papillary epithelial hyperplasia, a microscopic finding that correlates with the clinical finding of rough or stippled mucosa, as a predictor of PLGA. Accordingly, the specific aims of this study are as follows: (1) compare the frequency of surface papillary epithelial hyperplasia in PLGA versus other types of minor salivary gland neoplasms, (2) compare PLGA and other minor salivary gland neoplasms with respect to various clinical parameters (including demographic findings, site distribution, tumor size/consistency/color).
Materials and Methods

Study Design and Sample
We performed a retrospective review of the minor salivary gland neoplasms most frequently diagnosed by the Medical University of South Carolina College of Dental Medicine's oral pathology biopsy service from 1991 to 2013. Our review was limited to lesions arising in the oral cavity or soft palate with the following diagnoses: PLGA, pleomorphic adenoma (PA), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC). (Note that the soft palate represents a subsite of the oropharynx rather than the oral cavity.) We excluded the following: cases in which the diagnosis was uncertain, cases for which all written records (i.e., case history forms submitted by clinicians, pathology reports) or microscopic slides were not b Fig. 1 a, 
Data Collection
The following information was collected from the case history forms submitted by clinicians: patient age (at biopsy), gender, ethnicity, anatomic location, maximum tumor diameter, tumor color, tumor consistency, and clinical impression (clinical differential diagnosis). The pathology reports and microscopic slides for each case were reviewed in order to confirm the histopathologic diagnosis, as per the diagnostic criteria of the World Health Organization [6] . In addition, for each case in which surface epithelium was present for microscopic evaluation, the surface epithelium was characterized by one of the following descriptive categories: papillary epithelial hyperplasia present, pebbly or slightly irregular surface architecture (without concurrent papillary epithelial hyperplasia), no significant surface architectural change ( Fig. 2a-c) . If multiple biopsies were submitted for the same tumor, then data was recorded for the single case as a whole. Data was managed using Microsoft Excel 2010, and data entry was checked twice for accuracy.
Data Analysis
Statistical analysis was performed using SPSS (version 22.0) software (IBM Corporation, Armonk, NY). For each variable, descriptive statistics were calculated for each tumor type and the entire study sample. In addition, descriptive statistics were calculated for the non-PLGA (PA, ACC, MEC), benign (PA), and malignant (PLGA, ACC, MEC) tumor groups. Pearson Chi square analysis was performed to assess differences in gender and in the proportion of Caucasians and African Americans among the tumor types. One-way analysis of variance (ANOVA) was performed to assess differences in age at presentation and maximum tumor diameter among the tumor types. Similarly, for the PLGA versus non-PLGA and benign versus malignant tumor groups, Pearson Chi square analysis and one-way ANOVA were performed as described above to assess differences in gender, ethnicity, age, and maximum tumor diameter. Overall significance was set at p \ .05; in addition, a Bonferroni correction for multiple comparisons of 4 hypothesis tests was applied, with p \ .0125 considered significant. Fisher's exact test was performed to compare the presence and absence of surface papillary epithelial hyperplasia for the PLGA versus non-PLGA cases and the benign versus malignant cases. The cases with slightly pebbly surface epithelium and no significant surface architectural change comprised the ''absence of papillary epithelial hyperplasia'' group. In addition, the Fisher's exact test was used to assess surface epithelial features among the tumor types. Significance was set at p \ .05.
Results
A total of 202 cases met the study inclusion criteria. A summary of clinical features for each tumor type and the entire study sample is provided in Table (1) the mean age for the PLGA group was significantly greater than that for the PA and MEC groups but not the ACC group; (2) the mean tumor size for the PLGA group was significantly smaller than the ACC group but not significantly different from the PA and MEC groups. Each tumor type exhibited a predilection for the palate. Tumor color and consistency often were not stated (n = 60 and n = 90, respectively); however, the most frequently provided clinical descriptors for each tumor type were a pink/tan/normal color and firm/indurated/fibrous consistency.
Comparison of the PLGA versus non-PLGA groups (Table 2 ) and the benign versus malignant groups showed no significant differences in gender distribution, proportion of Caucasians and African Americans, or maximum tumor diameter (p [ .0125). The mean age for the PLGA group was significantly older than the non-PLGA group {one way ANOVA [F(1, 198) = 9.53, p = .002]}, and the mean age of the malignant group was modestly but significantly older than the benign group {one way ANOVA [F (1, 198 
Data regarding surface epithelial findings by tumor type is provided in Table 3 . Papillary epithelial hyperplasia of the surface epithelium was present in six PLGA cases and one MEC case. The increased frequency of surface papillary epithelial hyperplasia among the PLGA cases versus non-PLGA cases and benign versus malignant cases was significant [p = .0001 and p = .041, respectively]. The sensitivity and specificity of papillary epithelial hyperplasia for PLGA were 30 % (95 % confidence interval (CI) 12-54 %) and 99 % (95 % CI 94-100 %), respectively. The positive and negative predictive values of papillary epithelial hyperplasia for PLGA were 86 % (95 % CI 42-98 %) and 87 % (95 % CI 79-93 %), respectively.
All cases that exhibited surface papillary epithelial hyperplasia involved the palate (including six PLGA and one MEC that solely involved the palate, and six PLGA that involved both the palate and buccal mucosa). Interestingly, for one of the PLGA cases with surface papillary epithelial hyperplasia, the clinician noted a ''velvety'' surface. Microscopic examination showed tumor infiltrating the superficial lamina propria (Figs. 1e, f, 3a, b ) in the PLGAs with surface papillary epithelial hyperplasia. The Lower lip (n)
Floor of mouth (n) single case of MEC with surface papillary epithelial hyperplasia was unusual in that it exhibited tumor arising from the epithelium of a terminal salivary duct. For the PLGA cases, the clinical differential diagnoses provided by submitting clinicians included the following entities: PA (n = 13), canalicular adenoma (n = 2), MEC (n = 2), PLGA (n = 1), ACC (n = 1), salivary gland tumor (n = 2), ''adenoma'' (n = 3), mucocele (n = 2), sialolith (n = 1), sialadenitis (n = 2), abscess/periapical cyst/periapical granuloma (n = 5), fibroma/fibrous hyperplasia (n = 4), squamous cell carcinoma (n = 3), epithelial dysplasia (n = 1), epithelial hyperplasia (n = 1), hemangioma (n = 1), ''cyst'' (n = 1). No differential diagnosis was provided in 2 PLGA cases. Among the 42 suggested entities, the majority (n = 31, 74 %) were benign or reactive, whereas only 8 (19 %) were malignant. The submitting clinicians included oral and maxillofacial surgeons (n = 25) and general dentists (n = 3).
Discussion
Among the clinicopathologic parameters that we evaluated, surface papillary epithelial hyperplasia was notable for its close association with PLGA, albeit present in only a minority of cases. We surmise that this papillary epithelial hyperplasia represents a reactive process to underlying tumor; in particular, our microscopic observations suggest that this phenomenon tends to occur when PLGA polymorphous low-grade adenocarcinoma, non-PLGA cases adenoid cystic carcinoma, mucoepidermoid carcinoma, and pleomorphic adenoma a For these clinical parameters, it was possible for a single case to exhibit more than one characteristic tumor is present immediately beneath the surface epithelium. Therefore, the close association of surface papillary epithelial hyperplasia with PLGA compared to other common minor salivary gland tumor types simply may reflect an increased tendency for PLGA to infiltrate the superficial lamina propria. Accordingly, the single case of MEC that also showed overlying papillary epithelial hyperplasia was unusual in that it arose relatively superficially from the lining of a terminal salivary duct. With the exception of this single case of MEC, the non-PLGA cases in our study did not exhibit this combination of superficial tumor infiltration and overlying papillary epithelial hyperplasia.
To the best of our knowledge, reactive papillary epithelial hyperplasia arising in association with a minor salivary gland neoplasm has not been described previously. However, a similar phenomenon is known to occur in association with peripheral ameloblastoma [7] . This benign odontogenic neoplasm most often appears as a smoothsurfaced gingival nodule likened to a fibroma or pyogenic granuloma, although a subset of cases may exhibit a pebbly, warty, or papillary surface similar to that of a papilloma. Another reactive process of the palate is inflammatory papillary hyperplasia; this condition classically develops on the hard palatal mucosa beneath a denture base, particularly in patients with an ill-fitting prosthesis, poor denture hygiene, or continuous denture use without daily removal. Notwithstanding, in such cases the mucosa of the palatal vault or the entire hard palate appears pebbly, without an underlying mass lesion as one typically would see in PLGA. In salivary ductal papillomas, such as sialadenoma papilliferum, papillary surface change may be evident clinically; however, the papillary epithelial proliferation in these very rare tumors is an essential neoplastic component, rather than a reaction to underlying tumor.
Although this study was inspired by our interest in identifying clinical features (such as rough mucosa) that might aid in narrowing the differential diagnosis for patients with minor salivary gland neoplasms, our findings also suggest that overlying papillary epithelial hyperplasia may be a useful microscopic clue for identification of PLGA. In particular, it is often difficult to differentiate PLGA from ACC, because both tumors tend to exhibit basaloid cytologic features, perineural invasion, and areas with a cribriform growth pattern. In addition, cellular PA may mimic PLGA, because of bland cytologic features, diverse growth patterns, irregular pushing borders, and minimal mesenchymal elements [8] . However, distinguishing histopathologic features include the rounded, vesicular nuclei of PLGA compared to the typically hyperchromatic, angular nuclei of ACC and an increased tendency for a whorled growth pattern with peripheral, single-file cords in PLGA compared to ACC and PLGA. Immunohistochemical studies have noted increased expression of CD43, c-kit, and alpha-smooth muscle actin in ACC compared to PLGA and more frequent nuclear expression of galectin-3 and cyclin D1 in ACC compared to PLGA [9] [10] [11] [12] ; nevertheless, other investigations have questioned the diagnostic utility of these markers [10, 13, 14] . A more recent study by Rooper et al. [15] reported that a p63-positive/p40-negative immunophenotype was characteristic of PLGA but rare in ACC and absent in the cellular epithelial component of PA. In addition, some studies have found increased expression of glial fibrillary acid protein in PA compared to PLGA [16, 17] . In contrast to surface papillary epithelial hyperplasia, the other clinicopathologic parameters that we analyzed did not seem so helpful in distinguishing PLGA from other tumor types. All the tumor types that we examined most commonly involved the palate, which correlates with a well-established palatal predilection among minor salivary gland neoplasms overall. Demographic characteristics were similar across tumor types in our study and comparable to findings in previous studies. All the tumor types in our study exhibited a predilection for females and middle-aged to older adults, with peak age at diagnosis ranging from the 5th through 7th decades. Most previous large series and reviews of PLGA have reported female-to-male ratios of approximately 2:1 [2, 5, [18] [19] [20] , but some investigators have reported a greater female predilection comparable to that in our study (3.7:1) [3, 21] . The differences in gender distribution between tumor types in our study were not significant. The mean age at diagnosis for the PLGA group (60 years) was significantly older (by about a decade) than the MEC and PA groups but not significantly different than that for the ACC group. Also, the mean age for patients with PLGA in our study was comparable to the mean ages (ranging from 54 to 58 years) previously reported in large case series and reviews [18] [19] [20] . With regard to ethnicity, Caucasians comprised the majority of patients for all tumor types in our study. The proportion of African Americans among our PLGA cases (29 %) was similar to that reported in the Armed Forces Institute of Pathology (AFIP) series (27 %) and the Evans and Luna series (25 %) [5, 18] .
It is difficult to make conclusions based on the data we collected regarding tumor consistency and color, because many of the records that we reviewed did not provide this information. Nevertheless, all the tumor types were described most frequently as having a firm consistency and appearing pink, tan, or normal in color. Interestingly, among PAs, the second most frequently noted color was yellow (n = 21, 20 %), whereas a yellow hue was observed much less frequently (0-6 % of cases) in the other tumor types. This observation may be due to the presence of fatty tissue as a secondary element in many PAs. With regard to tumor size, the mean maximum tumor diameter was significantly greater for ACC than PLGA, MEC, and PA, although there was considerable overlap in size range among the different tumor types.
The challenge of recognizing PLGA based on clinical features alone is underscored by the varied differential diagnoses offered by submitting clinicians. Among the PLGA cases, in only one instance did a clinician specifically name PLGA in the differential diagnosis. Most favored benign or reactive processes over malignancies (74 vs. 19 % of suggested diagnoses, respectively); indeed, among the PLGA cases for which clinical differential diagnoses were provided, 50 % were presumed to represent PAs. Such erroneous clinical impressions are understandable for a low-grade malignancy. Furthermore, our analysis of the benign versus malignant tumors in this study showed no significant differences in gender distribution, ethnicity, and tumor size. Although the patients with malignant tumors were significantly older than those with benign tumors, this difference was modest (difference in mean age, approximately 7 years). In fact, both benign and malignant tumors occurred over a broad age range with considerable overlap. Despite the potential difficulty of clinically distinguishing between benign and malignant minor salivary gland neoplasia, the clinician's index of suspicion for malignancy is an important determinant of clinical management, with incisional biopsy typically recommended for lesions suspected to be malignant and excisional biopsy for lesions suspected to be benign or reactive.
Microscopic diagnosis is generally indicated for a patient with a persistent oral or soft palatal mass of unknown cause. However, if the risk for malignancy is perceived to be low, a patient may elect to delay diagnostic and treatment procedures. Unfortunately, such delay may have an adverse impact on patient outcome. Overall, PLGA has an excellent prognosis, with most large-scale series reporting local recurrence in only 9-17 % of cases, regional metastasis in 9-15 % of cases, and distant metastasis in very rare instances [6] . Notwithstanding, prompt diagnosis and treatment and long-term follow-up are critical. Tumor persistence or recurrence over long periods has been noted in rare cases of tumor-related deaths, and long-standing tumors potentially may undergo dedifferentiation [18, 19, 22] .
The retrospective nature of our study has certain limitations. For instance, it is possible that there may have been cases in which rough mucosa was present but was not sampled in the biopsy specimen. Therefore, the true frequency of rough mucosa and surface papillary epithelial hyperplasia in PLGA may be greater than what is suggested by our study results. In addition, we were unable to include symptoms and various clinical surface characteristics (e.g., telangiectasias, ulceration, smooth versus rough texture) in our statistical analysis because submitting clinicians provided such information in only a minority of cases. Instead, for evaluation of surface texture, we have used the microscopic finding of surface papillary epithelial hyperplasia as a surrogate marker for the clinical observation of rough mucosa. Also, we suspect that the rough surface produced by mild papillary epithelial hyperplasia might be overlooked unless an individual is trained to make careful clinical observation with adequate lighting and drying of the mucosa. In order to overcome these limitations, larger-scale prospective studies comparing PLGA within a broader spectrum of lesions are needed to validate our findings.
In conclusion, our findings suggest that surface papillary epithelial hyperplasia, which corresponds to the clinical observation of rough mucosa is a useful clue for identification of PLGA. This feature may be evident in only a minority of PLGA cases; however, when present within the context of a palatal salivary gland neoplasm, it suggests a high probability of PLGA. Given that the clinical presentation of PLGA tends to be nonspecific, familiarity with this subtle feature may be especially helpful for clinicians. An increased suspicion for malignancy in what otherwise may appear to be a benign tumor may prompt more timely and appropriate management. Large-scale, prospective studies with direct clinical and pathologic correlation for comparison of PLGA within a broader spectrum of lesion types are needed to confirm our findings.
